{"schema_version":"secwatch.filing_event.v1","accession":"0000051253-24-000039","form_type":"8-K","ticker":"IFF","cik":"0000051253","company_name":"INTERNATIONAL FLAVORS & FRAGRANCES INC","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.774625+00:00","generated_at":"2026-05-30T05:37:22.914694+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IFF Q3 sales up 4% to $2.93B, adj. EBITDA $568M, raises FY 2024 guidance","bullets":["GAAP EPS $0.23 vs. $0.28 last year; adjusted EPS ex-amortization $1.04, up from $0.81.","Currency-neutral comparable sales +9% YoY, driven by double-digit growth in Health & Biosciences and Scent.","Volume recovered high-single digits across all four business segments; Nourish and Pharma also positive.","Adjusted operating EBITDA $568M (19.4% margin) vs. $497M (17.5%) in Q3 2023.","Company raising full-year 2024 financial guidance citing Q3 strength and cautious Q4 optimism."],"urls":{"canonical":"https://secwatch.observer/filing/0000051253-24-000039","json":"https://secwatch.observer/filing/0000051253-24-000039.json","markdown":"https://secwatch.observer/filing/0000051253-24-000039.md","text":"https://secwatch.observer/filing/0000051253-24-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/51253/000005125324000039/0000051253-24-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/51253/000005125324000039/iff-20241105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:37:22.914694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}